Back
Fennec Pharmaceuticals 10K Form
Buy
71
FRX.TO
Fennec Pharmaceuticals
Last Price:
8.62
Seasonality Move:
19.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-30 | 10K | FRX.TO/Fennec Pharmaceuticals Annual |
| 2020-11-16 | 10Q | FRX.TO/Fennec Pharmaceuticals Quarterly |
| 2020-08-05 | 10Q | FRX.TO/Fennec Pharmaceuticals Quarterly |
| 2020-05-14 | 10Q | FRX.TO/Fennec Pharmaceuticals Quarterly |
| 2020-02-14 | 10K | FRX.TO/Fennec Pharmaceuticals Annual |
| 2019-11-12 | 10Q | FRX.TO/Fennec Pharmaceuticals Quarterly |
Receive FRX.TO News And Ratings
See the #1 stock for the next 7 days that we like better than FRX.TO
FRX.TO Financial Statistics
Sales & Book Value
| Annual Sales: | $28.69M |
|---|---|
| Cash Flow: | $-3.13M |
| Price / Cash Flow: | 7.56 |
| Annual Sales: | $-0.25 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.14360 |
|---|---|
| Net Income (TTM): | $-1.77M |
| Gross Margin: | $26.99M |
| Return on Equity: | 0% |
| Return on Assets: | -2.75% |
Fennec Pharmaceuticals Earnings Forecast
Key Fennec Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 15 years for FRX.TO is 94.08%.
- The Selling, General & Administrative Expenses for FRX.TO have been equal to 153.91% of Gross Profit Margin.
- The Research & Development expenses have been 0.26% of Revenue.
- The Interest Expense is -21.15% of Operating Income.
- The Net Earning history of FRX.TO is -75.50% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 12 years.
Fennec Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | TSX |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | FRX.TO |
| Website: | fennecpharma.com |
Debt
| Debt-to-Equity Ratio: | -6.21 |
|---|---|
| Current Ratio: | 7.8 |
| Quick Ratio: | 7.16 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 35.78 |
FRX.TO Technical Analysis vs Fundamental Analysis
Buy
71
Fennec Pharmaceuticals (FRX.TO)
is a Buy
Is Fennec Pharmaceuticals a Buy or a Sell?
-
Fennec Pharmaceuticals stock is rated a Buy
The current Fennec Pharmaceuticals [FRX.TO] share price is $8.65. The Score for FRX.TO is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.